Laurent Higueret Ph.D Overview
- Firm
- Bpifrance
- Primary Position
-
Senior Investmen...
- Primary Industry
-
Healthcare
- Active Board Seats
-
8
- Med. Deal Size
-
- Med. Valuation
-
Laurent Higueret Ph.D General Information
Biography
Dr. Laurent Higueret serves as Senior Investment Director at Bpifrance. He serves as a Board Member at Bioptimus, AQEMIA and Astraveus. He currently serves on the Boards of Directors of Treefrog Therapeutics, Owkin, Biom'Up, Poxel, and TxCell, and follows Bpifrance's investments in Cerenis and DBV Technologies. He joined Bpifrance's Large Venture Fund in early 2014 as an Investment Director, focusing primarily on healthcare investments. He served as Board Observer at Dynacure. Previously, he spent six years as an investment banker with BNP Paribas' Healthcare M&A Group and built a healthcare services startup. He served as Board Member at Voluntis. He is a Doctor of Pharmacy from the University of Bordeaux and holds a Master's Degree in Finance from EM Lyon Business School.
Contact Information
Address
- 6/8, Boulevard Haussmann
- Maisons-Alfort
- 75009 Paris
- France
Laurent Higueret Ph.D Positions (1)
| Firm name | Firm type | Title | Location | Industry | Since |
|---|---|---|---|---|---|
| Bpifrance | Investor | Senior Investment Director | Paris, France | Investor |
Laurent Higueret Ph.D Board Seats (8)
| Company | Industry | Ownership Status | Financing Status | Location | Since |
|---|---|---|---|---|---|
| AQEMIA | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Paris, France | |
| Astraveus | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Paris, France | |
| Biom'Up | Biotechnology | Privately Held (backing) | Formerly VC-backed | Saint-Priest, France | |
| Bioptimus | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Paris, France | |
| DNA Script | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Le Kremlin-Bicêtre, France |
Laurent Higueret Ph.D Lead Partner on Deals (9)
| Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
|---|---|---|---|---|---|---|
| Bioptimus | 19-Feb-2024 | Seed Round | Completed | Biotechnology | Paris, France | |
| Bioptimus | 19-Feb-2024 | Completed | Biotechnology | Paris, France | ||
| AQEMIA | 27-Nov-2023 | Completed | Drug Discovery | Paris, France | ||
| AQEMIA | 19-Oct-2022 | Completed | Drug Discovery | Paris, France | ||
| Astraveus | 09-Sep-2022 | Completed | Biotechnology | Paris, France | ||
| Treefrog Therapeutics | 13-Sep-2021 | Completed | Drug Delivery | Pessac, France | ||
| Dynacure | 05-Nov-2020 | Completed | Drug Discovery | France | ||
| Owkin | 06-May-2020 | Early Stage VC (Series A3) | Completed | Drug Discovery | New York, NY | |
| Biom'Up | 09-Sep-2015 | Later Stage VC (Series C) | Completed | Biotechnology | Saint-Priest, France |
Laurent Higueret Ph.D Network (276)
Board Members (127)
| Name | Company | Representing | Location | From |
|---|---|---|---|---|
| Ohad Hammer | Dynacure | Pontifax Venture Capital | France | |
| Richard Kender | Poxel | Self | Lyon, France | |
| DNA Script | LSP Management Group | Le Kremlin-Bicêtre, France | ||
| ENYO Pharma | Sofinnova Partners | Lyon, France | ||
| AQEMIA | AQEMIA | Paris, France |
Portfolio Executives (94)
| Name | Company | Role | Deal date | Location |
|---|---|---|---|---|
| Zelda Mariet Ph.D | Bioptimus | Co-Founder & Principal Research Scientist | 19-Feb-2024 | Paris, France |
| David Cahané | Bioptimus | Co-Founder, Directeur général & General Manager | 19-Feb-2024 | Paris, France |
| Bioptimus | Co-Founder & Principal Research Scientist | 19-Feb-2024 | Paris, France | |
| Bioptimus | Co-Founder, Directeur général délégué | 19-Feb-2024 | Paris, France | |
| Bioptimus | Co-Founder & Chief Technology Officer | 19-Feb-2024 | Paris, France |
Fund Team Members (55)
| Name | Investor | Fund | Fund Location |
|---|---|---|---|
| Hubert Hernandez | Bpifrance | The French Tech Seed | Paris, France |
| Nicolas Herschtel | Bpifrance | Large Venture | Paris, France |
| Bpifrance | Paris, France | ||
| Bpifrance | Paris, France | ||
| Bpifrance | Paris, France |
Laurent Higueret Ph.D Affiliated Funds (3)
| Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
|---|---|---|---|---|---|---|---|---|
| Large Venture | Bpifrance | Venture - General | Closed | 2016 | ||||
| Nuclear Enterprise Development Fund | Bpifrance | Infrastructure Core | Closed | 2014 | ||||
| The French Tech Seed | Bpifrance | Venture Debt | Closed | 2019 |
Laurent Higueret Ph.D FAQs
-
Who is Laurent Higueret Ph.D?
Dr. Laurent Higueret serves as Senior Investment Director at Bpifrance.
-
How much does Laurent Higueret Ph.D typically invest?
Laurent Higueret Ph.D's median deal size is .
-
What is Laurent Higueret Ph.D’s main position?
Laurent Higueret Ph.D’s primary position is Senior Investment Director.
-
What are the contact details for Laurent Higueret Ph.D?
Laurent Higueret Ph.D’s email address is la and his phone number is +33 01 .
-
How many active board seats does Laurent Higueret Ph.D hold?
Laurent Higueret Ph.D holds 8 board seats including AQEMIA, Astraveus, Biom'Up, Bioptimus, and DNA Script.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
